AstraZeneca Finds 90% Vaccine Success, Will Seek Approval
AstraZeneca said Monday that one of its coronavirus vaccine candidates achieved 90% effectiveness, while the average efficacy of its two dosing regimens hit only 70% — well below the rates recently...To view the full article, register now.
Already a subscriber? Click here to view full article